The National Center for Cancer Care and Research (NCCCR) of the Hamad Medical Corporation has urged cancer patients to take extra precautions to limit their exposure to Covid-19.

“The Department of Radiation Oncology at NCCCR understands and appreciates that patients who are facing cancer treatment, or a cancer diagnosis, during the Covid-19 pandemic may experience significant worry and anxiety regarding their treatment and their timely and safe accessibility to hospitals,” Dr Noora al-Hammadi, chair of the Department said.

“As a department, we would like to reassure our patients that all our radiotherapy-specific cancer services are open as usual. Our doctors are attending their weekly multidisciplinary tumour board meetings to discuss all cases as part of our ongoing efforts to ensure that everyone will be seen and treated without unwanted delays, which could compromise a patient’s treatment outcome,” Dr al-Hammadi added.

She said the Department of Radiation Oncology is committed to treating all radiotherapy patients effectively and in a safe manner.



Related Story